Your browser doesn't support javascript.
loading
Establishment of X-linked Alport syndrome model mice with a Col4a5 R471X mutation.
Hashikami, Kentarou; Asahina, Makoto; Nozu, Kandai; Iijima, Kazumoto; Nagata, Michio; Takeyama, Michiyasu.
Affiliation
  • Hashikami K; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi, Fujisawa, Kanagawa, 251-8555, Japan.
  • Asahina M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi, Fujisawa, Kanagawa, 251-8555, Japan.
  • Nozu K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Hyogo 651-0017, Japan.
  • Iijima K; Department of Pediatrics, Kobe University Graduate School of Medicine, Kobe, Hyogo 651-0017, Japan.
  • Nagata M; Department of Kidney and Vascular Pathology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8575, Japan.
  • Takeyama M; Pharmaceutical Research Division, Takeda Pharmaceutical Company Limited, 2-26-1, Muraoka-Higashi, Fujisawa, Kanagawa, 251-8555, Japan.
Biochem Biophys Rep ; 17: 81-86, 2019 Mar.
Article in En | MEDLINE | ID: mdl-30582011
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biochem Biophys Rep Year: 2019 Document type: Article Affiliation country: Japan Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Biochem Biophys Rep Year: 2019 Document type: Article Affiliation country: Japan Country of publication: Netherlands